Pathophysiology of leptospirosis.

Area of Science:

• Nephrology
• Infectious Diseases
• Pathophysiology

Background:

• Leptospirosis is a global zoonotic disease with severe manifestations including acute kidney injury (AKI) and pulmonary hemorrhage.
• AKI in leptospirosis often presents as nonoliguric with hypokalemia, suggesting tubular dysfunction precedes glomerular filtration rate decline.

Purpose of the Study:

• To investigate the molecular mechanisms of leptospirosis-induced AKI and pulmonary edema.
• To identify key tubular transporter alterations in the early and recovery phases of leptospirosis-associated AKI.

Main Methods:

• Analysis of tubular transporter expression (NHE3, AQP1, NKCC2, AQP2, ENaC, NKCC1) in experimental models and human studies.
• Correlation of transporter changes with AKI and pulmonary edema development and recovery.

Main Results:

• Leptospirosis induces decreased expression of proximal tubule transporters (NHE3, AQP1) and increased NKCC2.
• Reduced collecting duct water transporter AQP2 expression contributes to nonoliguric AKI, with increased expression during recovery.
• Pulmonary edema results from impaired alveolar fluid clearance due to altered sodium transporters (ENaC, NKCC1).

Conclusions:

• Leptospirosis-induced AKI is characterized by specific alterations in renal tubular transporters.
• Understanding these transporter changes aids in managing leptospirosis complications, including pulmonary edema.
• Antibiotic therapy and supportive measures like hemodialysis are crucial for severe leptospirosis cases.